Cingulate Inc. (CING) Live Share Price, Invest From India

Cingulate Inc. Stock Performance

as on July 21, 2026 at 2:16 pm IST

Day's Low
Day's High
$4.40
Day's Price Range
$4.64
$4.56
3.51%
Downside
1.75%
Upside
52 Week's Low
52 Week's High
$3.16
52-Week Price Range
$11.89
$4.56
30.70%
Downside
160.75%
Upside

Cingulate Inc. share price movements today

Previous Close: $4.54
Open: $4.53
Volume: 364.6K
Day's Low - High: $4.40 - $4.64
52 Week Low - High: $3.16 - $11.89

Cingulate Inc. Historical Returns

1 Month Return: -8.62 %
3 Month Return: -22.18 %
1 Year Return: -19.43 %
3 Year Return: -97.43 %
5 Year Return: 0 %

Cingulate Inc. Stock Fundamentals & Key Indicators

Check Cingulate Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$61.1M

EPS (TTM)

-2.3

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-23.7M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-225.11%

Cingulate Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cingulate Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Cingulate Inc.	BUY	$61.1M	NA	NA	0.00%	NA
Revolution Medicines Inc.	BUY	$39.6B	496.73%	NA	0.00%	NA
Vertex Pharmaceuticals Inc.	BUY	$123.3B	144.82%	28.82	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$70.9B	15.15%	16.53	29.65%	0.53%

Stock Returns calculator for Cingulate Inc. Stock including INR - Dollar returns

The Cingulate Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Cingulate Inc. investment value today

Current value as on today

₹90,146

Returns

-₹9,854

(-9.85%)

Returns from Cingulate Inc. Stock

-₹19,435 (-19.43%)

Dollar Impact

₹9,581 (+9.58%)

Analyst Recommendation on Cingulate Inc. Stock

Based on 10 analysts

BUY

70.00%

Buy

30.00%

Hold

0.00%

Sell

Based on 10 analysts, 70% of analysts recommend a 'BUY' rating for Cingulate Inc.. Average target price of $23

Cingulate Inc. Share Price Target

Get share price movements and forecasts by analysts on Cingulate Inc..

What analysts predicted

80.17%UPSIDE

Target Price

$23

Current Price

$4.56

Analyzed by

10 Analysts

Target

$23.00

Cingulate Inc. target price $23, a slight upside of 80.17% compared to current price of $4.56. According to 10 analysts rating.

Indian Investors' Interest in Cingulate Inc. Stock

Search interest for Cingulate Inc. Stock has decreased by -60% in the last 30 days, reflecting a downward trend in search activity.

Time period: June 21, 2026 to July 21, 2026

Change:-60% versus previous 30 day period

Cingulate Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	-	-3,849	-	-	12,982	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-5	-2	-3	-3	-6	-3	-4	-5	-5	-7
EBITDA	-5	-2	-3	-3	-6	-3	-4	-5	-5	-7
Interest Expense	0	408	0	50	0	96	138	573	1	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-5	-2	-3	-4	-6	-3	-4	-7	-6	-9
Income Tax Expense	0	0	-	-	-	-	-	-	-	-
Net Income	-5	-2	-3	-4	-6	-3	-4	-7	-6	-9
Net Profit Margin	0.00%	0.08%	0.00%	0.00%	-0.05%	0.00%	0.00%	0.00%	0.00%	0.00%

Cingulate Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0
Operating Income	-11	-7	-20	-17	-22	-15	-19
EBITDA	-11	-6	-19	-17	-22	-14	-19
Interest Expense	-	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0
Income Before Tax	-11	-7	-20	-17	-23	-16	-22
Income Tax Expense	0	0	0	0	0	0	-
Net Income	-11	-7	-20	-17	-23	-16	-22
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Cingulate Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-2	-3	-3	-6	-3	-4	-7	-6	-9
Operating Cash Flow	-8	-1	-3	-4	-4	-4	-4	-3	-6
Investing Cash Flow	0	0	0	0	-	0	-	0	0
Financing Cash Flow	9	1	13	6	1	4	1	8	21
Change in Cash	1	0	9	2	-2	0	-2	4	14

Cingulate Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-7	-20	-17	-23	-15	-22
Operating Cash Flow	-6	-10	-15	-15	-18	-17
Investing Cash Flow	0	0	0	0	0	0
Financing Cash Flow	7	26	4	9	30	16
Change in Cash	0	15	-11	-5	12	-1

Global Institutional Holdings in Cingulate Inc.

Funds	Holdings
Vanguard Group Inc	1.12%
Susquehanna International Group, LLP	0%
HRT FINANCIAL LLC	0.25%
LPL Financial Corp	0.09%
BlackRock Inc	0.17%

See all

Insights on Cingulate Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 369.5% return, outperforming this stock by 388.9%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 573.9% return, outperforming this stock by 671.3%
NEGATIVE IMPACT
Price Dip
In the last 3 years, CING stock has moved down by -97.4%

About Cingulate Inc.

Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using its drug delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company's lead product candidate is CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials for the treatment of ADHD in children, adolescents, and adults. It also develops CTx-2103 (buspirone), which is in a formulation stage for the treatment of anxiety. In addition, the company plans to initiate a clinical plan for CTx-1302 (dextroamphetamine) to treat ADHD. Cingulate Inc. was founded in 2012 and is headquartered in Kansas City, Kansas.

Organisation	Cingulate Inc.
Headquarters	1901 West 47th Place, Kansas City, KS, United States, 66205
Industry	Biotechnology
CEO	Dr. Matthew N. Brams M.D.
E-voting on shares	Click here to vote

Key Management of Cingulate Inc.

Name	Title
Mr. Thomas Dalton	Vice President of Investor & Public Relations
Mr. Downey Bryan Wade	Executive VP & Chief Commercial Officer
Dr. Matthew N. Brams M.D.	Co-Founder, Executive VP & Chief Medical Officer
Ms. Jennifer L. Callahan CPA	Executive VP, CFO & Secretary
Mr. Nilay D. Patel J.D.	Executive VP, Chief Legal Officer & Chief Compliance Officer
Dr. Raul R. Silva M.D.	Co-Founder, Executive VP & Chief Science Officer

FAQs

What is Cingulate Inc. share price today?

Cingulate Inc. share price today is $4.56 as on July 21, 2026 at 8:46 am IST at the close of the market. Cingulate Inc. share today touched a day high of $4.64 and a low of $4.40.

What is the 52 week high and 52 week low for Cingulate Inc. share?

Cingulate Inc. share touched a 52 week high of $11.89 on March 17, 2026 and a 52 week low of $3.16 on June 1, 2026. Cingulate Inc. stock price today i.e. July 21, 2026 at 8:46 am IST is closed at $4.56,which is 61.65% down from its 52 week high and 44.30% up from its 52 week low.

What is Cingulate Inc.'s market capitalisation today?

Cingulate Inc. market capitalisation is $0.00T as on July 21, 2026 at 8:46 am IST.

How to invest in Cingulate Inc. Stock (CING) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Cingulate Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cingulate Inc. Shares that will get you 0.3289 shares as per Cingulate Inc. share price of $4.56 per share as on July 21, 2026 at 8:46 am IST.

What is the minimum amount required to buy Cingulate Inc. Stock (CING) from India?

Indian investors can start investing in Cingulate Inc. (CING) shares with as little as ₹96.445 or $1 (as of July 21, 2026 at 5:38 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹964.45 in Cingulate Inc. stock (as per the Rupee-Dollar exchange rate as on July 21, 2026 at 5:38 pm IST). Based on Cingulate Inc. share’s latest price of $4.56 as on July 21, 2026 at 8:46 am IST, you will get 2.1930 shares of Cingulate Inc.. Learn more about fractional shares .